Our company is founded and led by pioneers in Treg biology and cell therapy.
At Sonoma Bio we believe in balance.
Sonoma Biotherapeutics is a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases by restoring balance to the immune system.
Founded by pioneers in Treg biology and cell therapy, we are employing proprietary platform technologies and approaches to develop a new generation of targeted and durable Treg cell therapies designed to cure autoimmune and inflammatory diseases.
Founding Story
Values In Action
Learn about our values and how we express them in our company culture.
Who We Are
Meet the people of Sonoma Bio.
